ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,526Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 2094

$724K Total Retail Price of All Prescriptions

Rank: 223 out of 2094

577 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 577 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

3% of this provider’s 577 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 13,126 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
WARFARIN SODIUM 688 638 1 11
SIMVASTATIN 579 505 2 1
LEVOTHYROXINE SODIUM 538 465 3 3
FUROSEMIDE 460 429 4 6
METOPROLOL TARTRATE 397 342 5 10
AMLODIPINE BESYLATE 387 347 6 2
OMEPRAZOLE 356 316 7 4
POTASSIUM CHLORIDE 323 290 8 24
DONEPEZIL HCL 309 309 9 20
SERTRALINE HCL 285 283 10 26
METFORMIN HCL 262 197 11 8
LISINOPRIL 261 242 12 7
FAMOTIDINE 261 240 12 34
METOPROLOL SUCCINATE 258 224 14 9
NAMENDA 216 216 15 32
ENALAPRIL MALEATE 191 148 16 25
HYDROCHLOROTHIAZIDE 189 166 17 12
RISPERIDONE 184 178 18 56
ESCITALOPRAM OXALATE 162 150 19 46
LACTULOSE 156 129 20 65
ALENDRONATE SODIUM 149 149 21 30
ZOLPIDEM TARTRATE 140 127 22 14
NAPROXEN 138 82 23 84
TRAZODONE HCL 131 117 24 72
DIOVAN 129 117 25 13
CITALOPRAM HBR 128 128 26 47
MIRTAZAPINE 122 122 27 43
ATORVASTATIN CALCIUM 120 102 28 5
DIGOXIN 117 108 29 51
IPRATROPIUM-ALBUTEROL 116 101 30 92
GABAPENTIN 110 100 31 23
PANTOPRAZOLE SODIUM 102 92 32 37
LIDODERM 92 92 33 59
ADVAIR DISKUS 92 84 33 36
CLONIDINE HCL 87 86 35 62
FLUTICASONE PROPIONATE 87 73 35 41
ATENOLOL 82 82 37 21
LANTUS 81 68 38 66
TAMSULOSIN HCL 77 76 39 29
NASONEX 75 61 40 194
QUETIAPINE FUMARATE 73 55 41 71
ALLOPURINOL 72 72 42 50
PROAIR HFA 69 49 43 45
CARVEDILOL 68 62 44 19
DIVALPROEX SODIUM ER 66 63 45 179
PAROXETINE HCL 66 66 45 77
BETAMETHASONE VALERATE 65 64 47 467
RAMIPRIL 62 49 48 48
PRAVASTATIN SODIUM 62 62 48 18
NIFEDIPINE ER 62 62 48 96
NEXIUM 60 55 51 16
CLOPIDOGREL 60 53 51 22
ZETIA 59 52 53 79
NITROGLYCERIN PATCH 59 52 53 101
OXCARBAZEPINE 58 58 55 257
OXYBUTYNIN CHLORIDE ER 58 58 55 138
GLIPIZIDE 58 50 55 82
CARBIDOPA-LEVODOPA 57 30 58 102
PREDNISONE 57 52 58 54
FENTANYL 57 57 S2 58 68
SPIRIVA 56 56 61 60
CEPHALEXIN 56 56 61 201
GLYBURIDE 56 41 R 61 95
TIZANIDINE HCL 54 54 64 254
OXYCODONE-ACETAMINOPHEN 53 53 S2 65 40
LOSARTAN POTASSIUM 52 33 66 17
DILTIAZEM 24HR CD 51 46 67 110
TRAVATAN Z 51 51 67 189
SANTYL 50 40 69 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.